Unlocking mystery of why dopamine freezes Parkinson's patients

August 11, 2008

Dopamine reshapes key brain circuits that control behavior

CHICAGO -- Parkinson's disease and drug addiction are polar opposite diseases, but both depend upon dopamine in the brain. Parkinson's patients don't have enough of it; drug addicts get too much of it. Although the importance of dopamine in these disorders has been well known, the way it works has been a mystery.

New research from Northwestern University's Feinberg School of Medicine has revealed that dopamine strengthens and weakens the two primary circuits in the brain that control our behavior. This provides new insight into why a flood of dopamine can lead to compulsive, addictive behavior and too little dopamaine can leave Parkinson's patients frozen and unable to move.

"The study shows how dopamine shapes the two main circuits of the brain that control how we choose to act and what happens in these disease states, " said D. James Surmeier, lead author and the Nathan Smith Davis Professor and chair of physiology at the Feinberg School. The paper is published in the August 8 issue of the journal Science.

These two main brain circuits help us decide whether to act out a desire or not. For example, do you get off the couch and drive to the store for an icy six-pack of beer on a hot summer night, or just lay on the couch?

One circuit is a "stop" circuit that prevents you from acting on a desire; the other is a "go" circuit that provokes you to action. These circuits are located in the striatum, the region of the brain that translates thoughts into actions.

In the study, researchers examined the strength of synapses connecting the cerebral cortex, the region of the brain involved in perceptions, feelings and thought, to the striatum, home of the stop and go circuits that select or prevent action.

Scientists electrically activated the cortical fibers to simulate movement commands and boosted the natural level of dopamine. What happened next surprised them. The cortical synapses connecting to the "go" circuit became stronger and more powerful. At the same time, dopamine weakened the cortical connections in the "stop" circuit.

"This could be what underlies addiction," Surmeier said. "Dopamine released by drugs leads to abnormal strengthening of the cortical synapses driving the striatal 'go' circuits, while weakening synapses at opposing 'stop' circuits. As a result, when events associated with drug taking - where you took the drug, what you were feeling - occur, there is an uncontrollable drive to go and seek drugs."

"All of our actions in a healthy brain are balanced by the urge to do something and the urge to stop," Surmeier said. "Our work suggests that it is not just the strengthening of the brain circuits helping select actions that is critical to dopamine's effects, it is the weakening of the connections that enable us to stop as well. "

In the second part of the experiment, scientists created an animal model of Parkinson's disease by killing dopamine neurons. Then they looked at what happened when they simulated cortical commands to move. The result: the connections in the "stop" circuit were strengthened, and the connections in the "go" circuit were weakened.

"The study illuminates why Parkinson's patients have trouble performing everyday tasks like reaching across a table to pick up a glass of water when they are thirsty," Surmeier said.

Surmeier explained the phenomenon using the analogy of a car. "Our study suggests that the inability to move in Parkinson's disease is not a passive process like a car running out of gas," he said. "Rather, the car doesn't' move because your foot is jammed down on the brake. Dopamine normally helps you adjust the pressure on the brake and gas pedals. It helps you learn that when you see a red light at an intersection, you brake and when the green light comes on, you take your foot off the brake and depress the gas pedal to go. Parkinson's disease patients, who have lost the neurons that release dopamine, have their foot perpetually stuck on the brake."

Understanding the basis for these changes in brain circuitry moves scientists closer to new therapeutic strategies for controlling these brain disorders and other involving dopamine like schizophrenia, Tourette's syndrome and dystonia.

Northwestern University

---

---

	Meet Your Happy Chemicals: Dopamine, Endorphin, Oxytocin, Serotonin by Loretta Graziano Breuning PhD (Author) Humans have emotional ups and downs because we’ve inherited the operating system of earlier mammals. You feel good when you find new rewards because that triggers dopamine. You feel good when you get respect because it triggers serotonin. Building trust triggers oxytocin, and endorphin makes you feel good when you’re injured. The mammal brain releases happy chemicals when you do things that promote survival in the state of nature. You can get more happy chemicals from your brain when you understand the job it evolved to do. Happy chemicals were not meant to surge all the time. They evolved to reward you when you promote the survival of your genes. You define this in unique individuals ways because early experience builds the neural pathways that turn on the happy chemicals. But...
	Dopamine Handbook by Leslie Iversen (Author), Susan Iversen (Author), Stephen Dunnett (Author), Anders Bjorklund (Author) The discovery of dopamine in 1957-1958 was one of the seminal events in the development of modern neuroscience, and has been extremely important for the development of modern therapies of neurological and psychiatric disorders. Dopamine has a fundamental role in almost all aspects of behavior: from motor control to mood regulation, cognition and addiction and reward, and dopamine research has been unique within the neurosciences in the way it has bridged basic science and clinical practice. Over the decades research into the role of dopamine in health and disease has been in the forefront of modern neuroscience. The Dopamine Handbook is the first single-volume publication to capture current progress and excitement in this dynamic research field.
	The Craving Brain: A bold new approach to breaking free from *drug addiction *overeating *alcoholism *gambling by Ronald A. Ruden (Author) Where do the roots of addictive behavior lie -- in our genes or in our environment, in our chemistry or in our character? In the Craving Brain, Dr. Ronald Ruden asserts that the roots of addiction most defintetly do not lie in our character. Rather, they lie in a complex chain reaction that originates in an ancient survival mechanism in the brain. When this system is inappropriately activated, it drives the body to crave, sometimes with addictive behavior as the end result. In clear, straightforward language, Dr. Ruden outlines his remarkable successful treatment program which he believes can cure this problem.The Craving Brain offers crucial insights into the world of addiction. This revolutionary book will bring hope to millions of people who suffer from a wide range of addictions, from...
	You Never Miss the Dopamine...: (until the brain runs dry!) by Bill Schmalfeldt (Author) From the author of "No Doorway Wide Enough," "Undercover Trucker," and "Hunky Dunk," a real-life look at how one man deals with his Parkinson's disease decline by laughing at it. Told in a series of essays from his blog, Bill Schmalfeldt talks more about the non-motor symptoms of PD -- the speech difficulties, the bizarre dreams, the memory problems and the hallucinations -- in a way that makes the reader realize that while there's no cure for PD, it can't damage the human spirit (unless you let it)!
	The Dopamine Receptors (The Receptors) by Kim A. Neve (Editor) As sites of action for drugs used to treat schizophrenia and Parkinson’s disease, dopamine receptors are among the most validated drug targets for neuropsychiatric disorders. Dopamine receptors are also drug targets or potential targets for other disorders such as substance abuse, depression, Tourette’s syndrome, and attention deficit hyperactivity disorder. Updated from the successful first edition, "The Dopamine Receptors" serves as a reference work on dopamine receptors while also highlighting the areas of research that are most active today. To achieve this goal, authors have written chapters that set a broad area of research in its historical context, rather than focusing on the research output of their own laboratories.
	The Dopaminergic Mind in Human Evolution and History by Fred H. Previc (Author) What does it mean to be human? There are many theories of the evolution of human behavior which seek to explain how our brains evolved to support our unique abilities and personalities. Most of these have focused on the role of brain size or specific genetic adaptations of the brain. In contrast, Fred Previc presents a provocative theory that high levels of dopamine, the most widely studied neurotransmitter, account for all major aspects of modern human behavior. He further emphasizes the role of epigenetic rather than genetic factors in the rise of dopamine. Previc contrasts the great achievements of the dopaminergic mind with the harmful effects of rising dopamine levels in modern societies and concludes with a critical examination of whether the dopaminergic mind that has evolved in...
	Imaging Dopamine by Paul Cumming (Author) Since its discovery 50 years ago, brain dopamine has been implicated in the control of movement and cognition, and is concerned with diverse brain diseases such as Parkinson's disease, schizophrenia and drug addiction. This book is an illustrated biography of the dopamine molecule, from its synthesis in the brain to its signalling mechanisms and ultimately to its metabolic breakdown. Using colour illustrations of positron emission tomography (PET) scans, each chapter presents a specific stage in the biochemical pathway for dopamine. Writing for researchers and graduate students, Paul Cumming presents a compilation of all that has been learned about dopamine through molecular imaging, a technology which allows the measurement of formerly invisible processes in the living brain. He reviews...
	Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance, Volume 172 (Progress in Brain Research) by Giuseppe Di Giovanni (Editor), Vincenzo Di Matteo (Editor), Ennio Esposito (Editor) This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the anatomy, pharmacology, physiology and behavioral data of the serotonin (5-HT)-dopamine (DA) interactions. Central serotonergic and dopaminergic systems play a critical role in the regulation of normal and abnormal behaviors. Moreover, recent evidence suggests that the dysfunction of the DA and 5-HT neurotransmitter systems contribute to various mental disorders including depression, schizophrenia, drug addiction and Parkinson's disease. This extremely important topic is of wide interest within the scientific community, with relevance not only to specialists but also to general practitioners and students. The book provides a valuable contribution to the debate on new pharmacological...
	Dumb Bells & Dopamine: A Parkinson's Success Story by Arthur Curren (Author) This book is about living with Parkinson's, an incurable, debilitating disease caused by the loss of dopamine-producing cells in the brain of the afflicted person. Levodopa is the only drug that replaces some of the dopamine and exercise is the only activity that induces the brain to produce dopamine. The author uses a rigorous exercise program to reduce the dosage of levodopa and extend the useful life of this essential drug. This is the author's dumb bells and dopamine approach to controlling Parkinson's.The author has also addressed some of the social issues related to the disease. This includes dealing with less than perfect physicians and with the negative situations that exist in the insurance industry and Social Security Administration.To provide real assistance to people with the...
	Overcoming qEEG Abnormalities and Reward Gene Deficits During Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine ... Therapy: Part 2 (Postgraduate Medicine) by JTE Multimedia Background It is well established that in both food- and drug-addicted individuals there is “dopamine resistance” associated with the DRD2 gene A1 allele. Based on earlier studies, evidence is emerging wherein the potential of utilizing a natural, nonaddicting, safe, putative D2 agonist may play a significant role in the recovery of individuals with reward deficiency syndrome, including those addicted to psychoactive chemicals. Findings Positive outcomes demonstrated by quantitative electroencephalographic (qEEG) imaging in a randomized, triple-blind, placebo-controlled, crossover study involving oral Synaptose Complex KB220Z™ showed an increase of alpha waves and low beta wave activity in the parietal brain region. Using t statistics, significant differences observed between...